228 results
424B2
BDX
Becton Dickinson & Co.
7 Feb 24
Prospectus for primary offering
5:22pm
to successfully continue technological innovation, successfully complete clinical trials, obtain and maintain regulatory approvals and registrations in the U.S
424B2
BDX
Becton Dickinson & Co.
7 Feb 24
Prospectus for primary offering
5:16pm
, including the potential inability to successfully continue technological innovation, successfully complete clinical trials, obtain and maintain regulatory
424B2
BDX
Becton Dickinson & Co.
5 Feb 24
Prospectus for primary offering
8:47am
development, including the potential inability to successfully continue technological innovation, successfully complete clinical trials, obtain and maintain
424B2
BDX
Becton Dickinson & Co.
5 Feb 24
Prospectus for primary offering
6:14am
;
Difficulties inherent in product development, including the potential inability to successfully continue technological innovation, successfully complete
8-K
EX-99.1
3v79l
1 Feb 24
BD Reports First Quarter Fiscal 2024 Financial Results
6:33am
8-K
EX-99.1
oy5aqps qkw3s
9 Nov 23
BD Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results
6:35am
8-K
EX-99.1
1t1uqzzrvim0g1dhi
3 Aug 23
BD Reports Third Quarter Fiscal 2023 Financial Results
6:34am
8-K
EX-99.1
fwtcug rmt37m61wl
4 May 23
BD Reports Second Quarter Fiscal 2023 Financial Results
6:36am
8-K
EX-99.1
e024n4ir e0d
10 Nov 22
BD Reports Fourth Quarter and Full Year Fiscal 2022 Financial Results
6:38am
8-K
EX-99.1
am3y17musu5
25 Aug 22
Departure of Directors or Certain Officers
4:16pm
424B2
lqnfucl8o
10 Aug 22
Prospectus for primary offering
4:06pm